Characteristics of patients with active cancer and venous thromboembolic complications receiving a chemotherapy treatment cycle (according to the ‘real-life’ clinical practice of Publicly Funded Health Facility: Moscow City Oncology Hospital No. 62 of Moscow Healthcare Department)
Introduction. Pulmonary embolism (PE) accounts for about 10% in the mortality pattern among cancer patients, which is the second most frequent cause of death.Aim. To identify and characterize patients with active cancer and VTEC receiving chemotherapy (CT) based on the retrospective review of medica...
Main Authors: | J. A. Fedotkina, O. O. Frolkova, D. Y. Kanner, A. A. Kalygin, E. P. Panchenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«REMEDIUM GROUP» Ltd.
2022-01-01
|
Series: | Атеротромбоз |
Subjects: | |
Online Access: | https://www.aterotromboz.ru/jour/article/view/255 |
Similar Items
-
Modern approaches to the prevention of venous thromboembolic complications in patients with active cancer
by: Yu. A. Fedotkina, et al.
Published: (2023-01-01) -
PROPHYLAXIS OF VENOUS THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ACTIVE ONCOLOGICAL DISEASE, RECEIVING MEDICAL ANTI-CANCER CHEMOTHERAPY IN OUTPATIENT CONDITIONS. ROLE OF APIXABAN
by: Yu. A. Fedotkina, et al.
Published: (2020-01-01) -
Markers of hemostasis activation and endothelial damage in patients with active cancer
by: A. B. Dobrovolsky, et al.
Published: (2022-06-01) -
CURRENT TREATMENT FOR VENOUS THROMBOSIS
by: P. S. Laguta
Published: (2015-12-01) -
PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH CANCER
by: Ju. A. Fedotkina
Published: (2019-06-01)